These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11266882)

  • 1. Posttransplant immune monitoring of anti-HLA antibody.
    Kerman RH; Katz SM; Van Buren CT; Ruth J; McKissick E; Rasmussen S; Kahan BD
    Transplant Proc; 2001; 33(1-2):402. PubMed ID: 11266882
    [No Abstract]   [Full Text] [Related]  

  • 2. Addition of rapamycin to cyclosporine-prednisone based immunosuppression reduces the clinical risk of pretransplant anti-HLA antibody.
    Kerman RH; Katz SM; Van Buren CT; Garcia C; Kahan BD
    Transplant Proc; 2001; 33(1-2):401. PubMed ID: 11266881
    [No Abstract]   [Full Text] [Related]  

  • 3. Pretransplant and posttransplant monitoring of anti-HLA class I IgG1 antibodies by ELISA identifies patients at high risk of graft loss.
    Monteiro F; Mineiro C; Rodrigues H; de Paula FJ; Kalil J
    Transplant Proc; 1997; 29(1-2):1433-4. PubMed ID: 9123368
    [No Abstract]   [Full Text] [Related]  

  • 4. The significance of the IgG anti-B-cell crossmatch on renal transplant outcome.
    Ghasemian SR; Light JA; Currier CB; Sasaki T; Aquino A; Rees J; Ward W; Carr J
    Clin Transplant; 1997 Oct; 11(5 Pt 2):485-7. PubMed ID: 9361946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class I and class II antibodies: monitoring before and after kidney transplantation and their clinical relevance.
    Schönemann C; Groth J; Leverenz S; May G
    Transplantation; 1998 Jun; 65(11):1519-23. PubMed ID: 9645818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of HLA disparity, immunosuppressive regimen used, and type of kidney allograft on production of anti-HLA class-I antibodies after transplant and occurrence of rejection.
    Abdelnoor AM; Ajib R; Chakhtoura M; Daouk M; Medawar W; Uwaydah M; Sawah SI; Khauli RB
    Immunopharmacol Immunotoxicol; 2009; 31(1):83-7. PubMed ID: 18752168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
    Shoker A; Klassen J; Herbut B
    Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
    Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sensitized recipient: What is to be done?
    Hippen B
    Am J Transplant; 2006 Oct; 6(10):2230-1. PubMed ID: 16952293
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of interferon alpha in allograft rejection.
    Benizri EJ; Gugenheim J; Bernard G; Tovey MG
    Transplant Proc; 1995 Feb; 27(1):413. PubMed ID: 7879043
    [No Abstract]   [Full Text] [Related]  

  • 12. Requirement for DR sharing in stable kidney allograft tolerance induced by donor bone marrow in rhesus monkeys.
    Thomas J; Kasten-Jolly J; Verbanac K; Smith JP; Carver M; Gross U; Rebellato L; Thomas F; Haisch C
    Transplant Proc; 1995 Feb; 27(1):686-8. PubMed ID: 7879146
    [No Abstract]   [Full Text] [Related]  

  • 13. Six-year experience with a triple drug protocol in renal transplantation: analysis of risk factors.
    Pallardó LM; Sánchez P; Sánchez J; García J; Orero E; Beneyto I; Cruz JM
    Transplant Proc; 1992 Dec; 24(6):2714-5. PubMed ID: 1465911
    [No Abstract]   [Full Text] [Related]  

  • 14. Post-transplant anti-HLA class II antibodies as risk factor for late kidney allograft failure.
    Campos EF; Tedesco-Silva H; Machado PG; Franco M; Medina-Pestana JO; Gerbase-DeLima M
    Am J Transplant; 2006 Oct; 6(10):2316-20. PubMed ID: 16925566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of posttransplant HLA class I and class II antibodies on renal graft outcome.
    Piazza A; Poggi E; Borrelli L; Valeri M; Buonomo O; Servetti S; Adorno D; Casciani CU
    Transplant Proc; 2001; 33(1-2):478-80. PubMed ID: 11266917
    [No Abstract]   [Full Text] [Related]  

  • 16. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
    Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
    Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of HLA class I and II antibodies by ELISA and complement-dependent cytotoxicity before and after transplantation.
    Christiaans MH; Nieman F; van Hooff JP; van den Berg-Loonen EM
    Transplantation; 2000 Mar; 69(5):917-27. PubMed ID: 10755551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HLA antibodies detected in posttransplant renal allograft recipient sera correlate with chronic rejection.
    Kerman RH; Susskind B; Kerman DH; Lam M; Gerolami K; Williams J; Kalish R; Campbell M; Katz SM; Van Buren CT; Kahan BD
    Transplant Proc; 1997; 29(1-2):1515-6. PubMed ID: 9123406
    [No Abstract]   [Full Text] [Related]  

  • 19. Relevance of positive crossmatches in renal transplantation.
    Horsburgh T; Mistry N; Weston S; Morgan J; Donnelly PK; Veitch PS; Bell PR
    Transplant Proc; 1992 Dec; 24(6):2508-9. PubMed ID: 1465848
    [No Abstract]   [Full Text] [Related]  

  • 20. IgM and IgG alloantibody responses to MHC class I and II following rat renal allograft rejection. Effects of transplantectomy and posttransplantation blood transfusion.
    Wray DW; Baldwin WM; Sanfilippo F
    Transplantation; 1992 Jan; 53(1):167-74. PubMed ID: 1370736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.